1. Home
  2. GLMD vs YOSH Comparison

GLMD vs YOSH Comparison

Compare GLMD & YOSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • YOSH
  • Stock Information
  • Founded
  • GLMD 2000
  • YOSH 2016
  • Country
  • GLMD Israel
  • YOSH United States
  • Employees
  • GLMD N/A
  • YOSH N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • YOSH Restaurants
  • Sector
  • GLMD Health Care
  • YOSH Consumer Discretionary
  • Exchange
  • GLMD Nasdaq
  • YOSH Nasdaq
  • Market Cap
  • GLMD 5.9M
  • YOSH 6.4M
  • IPO Year
  • GLMD 2014
  • YOSH 2022
  • Fundamental
  • Price
  • GLMD $2.80
  • YOSH $3.41
  • Analyst Decision
  • GLMD
  • YOSH
  • Analyst Count
  • GLMD 0
  • YOSH 0
  • Target Price
  • GLMD N/A
  • YOSH N/A
  • AVG Volume (30 Days)
  • GLMD 66.9K
  • YOSH 56.0K
  • Earning Date
  • GLMD 11-29-2024
  • YOSH 11-19-2024
  • Dividend Yield
  • GLMD N/A
  • YOSH N/A
  • EPS Growth
  • GLMD N/A
  • YOSH N/A
  • EPS
  • GLMD N/A
  • YOSH N/A
  • Revenue
  • GLMD N/A
  • YOSH $11,652,880.00
  • Revenue This Year
  • GLMD N/A
  • YOSH N/A
  • Revenue Next Year
  • GLMD N/A
  • YOSH N/A
  • P/E Ratio
  • GLMD N/A
  • YOSH N/A
  • Revenue Growth
  • GLMD N/A
  • YOSH 25.97
  • 52 Week Low
  • GLMD $2.73
  • YOSH $2.73
  • 52 Week High
  • GLMD $23.80
  • YOSH $13.86
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 37.59
  • YOSH 37.51
  • Support Level
  • GLMD $2.84
  • YOSH $2.80
  • Resistance Level
  • GLMD $3.05
  • YOSH $3.76
  • Average True Range (ATR)
  • GLMD 0.24
  • YOSH 0.70
  • MACD
  • GLMD 0.04
  • YOSH -0.10
  • Stochastic Oscillator
  • GLMD 8.33
  • YOSH 21.66

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

About YOSH Yoshiharu Global Co.

Yoshiharu Global Co is a restaurant operator. The company has one reportable segment, consisting of operating its stores. Yoshiharu serves the perfect, ideal ramen, as well as offers customers a wide variety of sushi, bento menus, and other favorite Japanese cuisines. It owns and operates restaurant stores.

Share on Social Networks: